Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Essential hypertension is, at least in many subjects, associated with a decrease in insulin sensitivity, whereas glycemic control… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
1991
1991
1. This study investigated the influence of age on the pharmacokinetics, pharmacodynamics, general tolerability and concentration… Expand
Review
1990
Review
1990
Dilevalol, the RR-stereoisomer of labetalol, is a non-cardioselective beta-adrenoceptor antagonist with substantial partial beta… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • table II
1990
1990
Summary: Sixty-one patients (41 men, 20 women) aged 29-73 years, with moderate to severe hypertension, were enrolled in a… Expand
Highly Cited
1989
Highly Cited
1989
We compared dilevalol (an isomer of labetalol), 200-400 mg daily, against atenolol, 50-100 mg daily, in a double-blind, crossover… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1989
1989
Dilevalol combines vasodilation due to selective beta 2 agonism and nonselective beta antagonism. We studied 311 patients… Expand
1988
1988
The bioavailability and pharmacokinetics of dilevalol following oral and intravenous administration were investigated in 12… Expand
1988
1988
Dilevalol combines a nonselective blocking action on beta-receptors with selective beta 2-agonist activity. In this double-blind… Expand
1988
1988
A single high-performance liquid chromatographic (HPLC) assay for the quantitative determination of dilevalol, the R,R isomer of… Expand
1988
1988
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The… Expand